Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Invested Capital (2022 - 2025)

Burning Rock Biotech has reported Return on Invested Capital over the past 4 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.0% at Burning Rock Biotech, up from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2025 and troughed at 0.01% in Q4 2022.
  • A 4-year average of 0.01% and a median of 0.01% in 2023 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2023 and later grew 1bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.01% in 2022, then grew by 1bps to 0.01% in 2023, then skyrocketed by 33bps to 0.01% in 2024, then skyrocketed by 83bps to 0.0% in 2025.
  • Business Quant data shows Return on Invested Capital for BNR at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.